XML 57 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisition of Insight - Schedule of Fair Value of Contingent Consideration Liability (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Contractual Value   $ 6,000
Fair Value on the Merger Date $ 8,180 7,120
Milestone 1 [Member]    
Contractual Value   1,500
Fair Value on the Merger Date   1,340
Milestone 2 [Member]    
Contractual Value   3,000
Fair Value on the Merger Date   1,830
Milestone 3 [Member]    
Contractual Value [1]   1,500
Fair Value on the Merger Date [1]   770
Royalty 1 [Member]    
Contractual Value [2]  
Fair Value on the Merger Date [2]   5,980
Royalty 2 [Member]    
Contractual Value [2]  
Fair Value on the Merger Date [2]   $ 1,210
[1] Indicates the maximum payable if the Milestone achieved.
[2] Royalty Payments are based on a percentage of future revenues of DetermaIO and Pharma Services over their respective useful life, as defined, accordingly, there is no fixed contractual value for the Royalty Contingent Consideration.